UnitedHealth Group Inc (NYSE:UNH) CEO Larry Renfro sold 22,598 shares of the firm’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the sale, the chief executive officer now owns 195,314 shares in the company, valued at approximately $43,310,879.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Shares of UnitedHealth Group Inc (UNH) traded down $2.31 during midday trading on Friday, hitting $220.46. 2,274,987 shares of the stock traded hands, compared to its average volume of 2,669,704. The firm has a market capitalization of $215,879.17, a price-to-earnings ratio of 24.44, a price-to-earnings-growth ratio of 1.65 and a beta of 0.66. UnitedHealth Group Inc has a 1-year low of $156.09 and a 1-year high of $231.77. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. The firm had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the business posted $2.17 earnings per share. equities analysts expect that UnitedHealth Group Inc will post 9.99 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Friday, December 1st were given a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a yield of 1.36%. UnitedHealth Group’s payout ratio is presently 33.26%.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. BlackRock Inc. boosted its position in UnitedHealth Group by 1.2% during the second quarter. BlackRock Inc. now owns 69,430,416 shares of the healthcare conglomerate’s stock worth $12,873,786,000 after acquiring an additional 796,654 shares during the last quarter. Vanguard Group Inc. raised its stake in UnitedHealth Group by 2.5% during the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after purchasing an additional 1,588,516 shares during the period. FMR LLC raised its stake in UnitedHealth Group by 2.1% during the second quarter. FMR LLC now owns 56,101,668 shares of the healthcare conglomerate’s stock worth $10,402,371,000 after purchasing an additional 1,168,324 shares during the period. Alliancebernstein L.P. raised its stake in UnitedHealth Group by 2.3% during the second quarter. Alliancebernstein L.P. now owns 7,906,936 shares of the healthcare conglomerate’s stock worth $1,466,104,000 after purchasing an additional 174,290 shares during the period. Finally, TIAA CREF Investment Management LLC raised its stake in UnitedHealth Group by 3.9% during the second quarter. TIAA CREF Investment Management LLC now owns 5,882,427 shares of the healthcare conglomerate’s stock worth $1,090,720,000 after purchasing an additional 223,524 shares during the period. Hedge funds and other institutional investors own 86.01% of the company’s stock.

Several analysts recently commented on UNH shares. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, October 10th. Cantor Fitzgerald restated a “buy” rating and set a $225.00 price target on shares of UnitedHealth Group in a research report on Monday, November 27th. ValuEngine lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. Piper Jaffray Companies raised their price target on shares of UnitedHealth Group to $228.00 and gave the company an “overweight” rating in a research report on Tuesday, October 17th. Finally, Jefferies Group restated a “buy” rating and set a $248.00 price target on shares of UnitedHealth Group in a research report on Friday, December 1st. Three analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company. UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $224.98.

TRADEMARK VIOLATION NOTICE: This news story was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another site, it was copied illegally and reposted in violation of United States & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.americanbankingnews.com/2017/12/18/unitedhealth-group-incorporated-unh-ceo-larry-c-renfro-sells-22598-shares.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.